AstraZeneca Partners with Insitro in USD1.5 Billion AI Drug Discovery Deal Written By sheeba farhat16 Oct 2026 3:32 PM ISTLondon: AstraZeneca has teamed up with artificial intelligence biotech company insitro to discover and develop new treatments for difficult to treat...
Summit, AstraZeneca and Daiichi Sankyo Plan Phase III Trial in Triple-Negative Breast Cancer Written By sheeba farhat4 Oct 2026 10:28 PM ISTBengaluru: Summit Therapeutics on Friday announced a clinical trial collaboration with AstraZeneca and Daiichi Sankyo to test their cancer drug...
AstraZeneca Gets CDSCO Panel Nod to Import, Market Camizestrant for Breast Cancer Written By Susmita Roy4 Oct 2026 10:08 PM ISTNew Delhi: Citing an unmet medical need, the Subject Experts Committee (SEC) has granted permission to AstraZeneca Pharma India Limited to import...
AstraZeneca Files USFDA Application for ORPATHYS-TAGRISSO Combo in Advanced Lung Cancer Written By sheeba farhat29 Sept 2026 10:00 AM ISTNew Delhi: HUTCHMED (China) said on Tuesday ​that Anglo-Swedish drugmaker AstraZeneca ‌had applied to the US Food and Drug Administration for approval...
Roche's Enicepatide Delivers 15.5% Weight Loss, Improves Blood Sugar in Diabetes Trial Written By sheeba farhat23 Sept 2026 1:00 PM ISTNew Delhi: Swiss drugmaker Roche said on Tuesday its experimental dual-acting obesity drug helped overweight or obese patients with type 2 ​diabetes...
AstraZeneca, Daiichi Sankyo's Enhertu Gets NICE Nod for NHS Use in England for HER2-Low Breast Cancer Written By sheeba farhat18 Sept 2026 10:10 PM ISTLondon: AstraZeneca and Daiichi Sankyo said on Thursday their breast cancer treatment Enhertu has been approved for use in England's state-run...
AstraZeneca's Breast Cancer Drug Camizestrant Fails Main Goal in Late-Stage Trial Written By sheeba farhat12 Sept 2026 6:30 PM ISTBengaluru: AstraZeneca's breast cancer pill failed to meet the main goal of improving progression-free survival in a late-stage trial, the company...
AstraZeneca Halts Phase 3 Volrustomig Lung Cancer Trial After Setback Written By sheeba farhat18 Aug 2026 10:08 PM ISTBengaluru: AstraZeneca is discontinuing a late-stage trial that tested experimental drug volrustomig plus chemotherapy in patients with metastatic...
Lupin Gets USFDA Nod for Generic Lokelma, Enters USD 568M US Hyperkalemia Market Written By Parthika Patel11 Aug 2026 11:30 PM ISTMumbai: Global pharmaceutical major Lupin Limited has received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New...
AstraZeneca Gets CDSCO Nod to Market Enhertu for New Breast Cancer Indication Written By Parthika Patel8 Aug 2026 9:00 PM ISTBengaluru: AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organization (CDSCO), Directorate General...
Moderna Secures USFDA Approval for First mRNA-Based Seasonal Flu Vaccine mFlusiva Written By sheeba farhat7 Aug 2026 8:56 PM ISTBengaluru: The U.S. Food and Drug Administration has approved Moderna's flu vaccine for people aged 50 and older, the company said on Wednesday,...
AstraZeneca, Bristol Myers Squibb Not in Merger Talks, No Deal Under Discussion: Report Written By sheeba farhat6 Aug 2026 5:36 PM ISTLondon: There are "no discussions" ongoing between AstraZeneca and Bristol Myers Squibb over a potential deal, a senior source close to the matter...
